Medical Action Industries, a supplier of medical and disposable surgical products, has appointed John Sheffield as chief financial officer (CFO) and corporate secretary. He will join the executive team responsible for strategy, planning and operations, and will oversee the company’s finance, accounting and investor relation functions.
Sheffield brings 20 years of financial, accounting and strategic transaction experience to Medical Action. He joins from Bank of America Merrill Lynch where he was a senior investment banker providing strategic and financial advice primarily to middle market companies. In addition, Sheffield has worked with other premier investment banks providing advice on mergers and acquisitions (M&As), as well as debt and equity financings. He has represented companies across several industries, with a particular focus on healthcare.
Previously, Sheffield was vice president of corporate development for ReAble Therapeutics (now known as DJO), a portfolio company of the Blackstone Group and global manufacturer of orthopaedic medical devices and services. He began his career as a certified public accountant (CPA) with a predecessor of PricewaterhouseCoopers (PwC).
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.